+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

M

Actively Recruiting

Researchers are studying Medicare beneficiaries with Lumbar Spinal Stenosis LSS and Neurogenic Claudication NC to compare outcomes after two different procedures MILD Percutaneous Image-Guided Lumbar Decompression and Interspinous Process Decompression IPD. This observational study tracks patients treated since January 1, 2017, evaluating the rates of surgical and minimally invasive interventions as well as any harms related to these procedures over 24 months. The study uses Medicare claims data and does not require prior patient consent or IRB oversight. The study includes two groups of patients those who received the MILD procedure, involving partial decompression under image guidance by removing tissue and bone at the affected spinal level, and those who underwent IPD, a device-based decompression technique. Both groups are observed through Medicare data for two years after their initial procedure to assess the need for further surgeries or interventions and to monitor for any complications. Participants are followed for 24 months after their index procedure using Medicare claims data. Researchers monitor the rates of harms associated with the initial treatment and the frequency of additional surgical or minimally invasive interventions. Since this is an observational study, data collection relies on existing Medicare records without direct patient involvement, and the study will continue enrolling patients until the sponsor stops it.

Age: 18Years +All Genders
2393 locations
E

Actively Recruiting

Healthy Volunteer

Researchers are exploring how multi-cancer detection MCD tests might work as tools to screen for multiple cancers at once in adults aged 45 to 75 without cancer. The study aims to understand the performance of two different MCD tests compared to a control group and how patients and doctors handle both normal and abnormal test results. This feasibility study will inform future trials and help improve early cancer detection when treatment is most effective. Participants will be randomly assigned to one of three groups one group will undergo the Shield MCD test, another the Avantect MCD test, and the third will serve as a control group with blood collection only. Blood samples are collected at enrollment and again after one year. Participants at unblinded sites receive their test results, and those with abnormal findings follow up with their clinicians for further testing. After the active study period, participants are followed passively for up to 10 years. During the study, participants complete questionnaires and provide blood samples on schedule. Researchers collect medical record data and monitor participant adherence, diagnostic outcomes, anxiety related to testing, and the accuracy of the tests in predicting cancer origins. Primary outcomes include enrollment feasibility, questionnaire completion, blood sample provision, and follow-up retention. Secondary outcomes evaluate diagnostic resolution, complications, and psychological impact. This comprehensive approach helps assess the practical aspects of MCD testing and its potential role in cancer screening.

Age: 45Years - 75YearsAll GendersPhase Not Applicable
45 locations